|
Volumn 43, Issue 9, 1996, Pages 688-691
|
Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases
a a a a a a a a |
Author keywords
5 fluorouracil; Hepatic arterial infusion; Interleukin 2; Liver metastases; Mitomycin C
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
IMMUNOLOGIC AGENT;
MITOMYCIN C;
RECOMBINANT INTERLEUKIN 2;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
CANCER SURVIVAL;
CHOLANGITIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL CANCER;
FEMALE;
FEVER;
GASTRITIS;
HEPATIC ARTERY;
HEPATITIS;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
LIVER METASTASIS;
LIVER RESECTION;
LUNG METASTASIS;
MALE;
PELVIS;
PEPTIC ULCER;
PRIORITY JOURNAL;
RECURRENT CANCER;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HEPATECTOMY;
HUMANS;
IMMUNOTHERAPY;
INFUSIONS, INTRA-ARTERIAL;
INTERLEUKIN-2;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
MITOMYCIN;
NEOPLASM RECURRENCE, LOCAL;
SURVIVAL RATE;
TIME FACTORS;
|
EID: 0029998250
PISSN: 01726390
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (24)
|
References (6)
|